BD's overall topline in the fourth quarter of fiscal 2024 benefits from revenue growth in all segments.
The headline numbers for Becton Dickinson (BDX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Becton Dickinson (BDX) came out with quarterly earnings of $3.81 per share, beating the Zacks Consensus Estimate of $3.77 per share. This compares to earnings of $3.42 per share a year ago.
Becton Dickinson surpassed analysts' expectations for fourth-quarter results on Thursday, helped by strong demand for its drug-delivery devices.
Continued solid uptake of BD's products is expected to have driven fiscal fourth-quarter revenues.
Get a deeper insight into the potential performance of Becton Dickinson (BDX) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. I expect 13 companies to announce their annual increases in the first half of November, including double-digit increases from Automatic Data Processing, Roper Technologies, and Snap-on. Investors saw good 10%+ increases from insurer Brown & Brown, payment processor Visa, and specialty chemical company RPM in October.
BD announces the BD Intraosseous Vascular Access System to enable quick vascular access for critical care situations.
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Becton Dickinson (BDX) possesses solid growth attributes, which could help it handily outperform the market.